Long School of Medicine

Search

Dimpy Shah, MD, PhD, assistant professor, Department of Population Health Sciences, was interviewed for this article.   Read More

Dimpy Shah, MD, PhD, assistant professor, Department of Population Health Sciences, was interviewed for this article.   Read More

Taylor Eighmy, PhD, acting president of UT Health San Antonio and president of UTSA, Francisco Cigarroa, MD, senior executive vice president for Health Affairs and Health System, and Jennifer Sharpe Potter, PhD, MPH, senior vice president for research, founding director of Be Well Institute on Substance Use and Related Disorders and professor of psychiatry and […]

Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that […]

Content provided by Claire Kowalick A study published in the International Wound Journal conducted by researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) revealed risk factors for reinfection after treatment of a diabetic foot infection. The study found nearly half of patients who receive treatment for diabetic foot infections will experience […]

Jason Bowling, MD, Department of Medicine, Division of Infectious Diseases, was interviewed for this article.   Read More

Jason Bowling, MD, Department of Medicine, Division of Infectious Diseases, was interviewed for the program “On the Record with Randy Beamer.”   Watch Now

Five years after the height of the SARS-CoV-2 (COVID-19) pandemic, scientists are beginning to unveil the infection’s potential long-term effects on the brain. We now know that following an acute COVID-19 infection, between 10% and 35% of people suffer from lingering effects called long COVID. For some people, these effects can be mild and short-lived, […]

Hispanics face nearly double the risk of developing Alzheimer’s disease compared to non-Hispanic whites, according to the National Institutes of Health National Institute on Aging.

Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed for this article.   Read More